At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 10 Jul 1998 No-Development-Reported for Bacterial infections in United Kingdom (Unknown route)
- 12 Jul 1995 New profile
- 12 Jul 1995 Preclinical development for Bacterial infections in United Kingdom (Unknown route)